Literature DB >> 1185864

Medical therapy in idiopathic retroperitoneal fibrosis.

M G Ochsner, W Brannan, H S Pond, J S Goodlet.   

Abstract

Except for its linkage with the ergot derivatives retroperitoneal fibrosis is a disease of unknown etiology. Two cases in which the traditional surgical approach was used but with the subsequent use of steroids are presented. The third patient was treated with steroids alone. The use of steroids alone is suggested for a limited number of poor risk patients when certain criteria are met.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185864     DOI: 10.1016/s0022-5347(17)67122-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Follow-up of a case of retroperitoneal fibroses treated sequencially via right side autotransplant and left uterolysis with wrapper of posterior preperitoneal fat.

Authors:  G C Peñalver; T A Sánchez; D R Gonzalez; R A Antolin; A F Benites; L O Galvis
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Idiopathic retroperitoneal fibrosis.

Authors:  N Bullock
Journal:  BMJ       Date:  1988-07-23

3.  Idiopathic retroperitoneal fibrosis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25

4.  Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis.

Authors:  A S Scavalli; A Spadaro; V Riccieri; G P Ricciuti; E Taccari; M Marini; A Zoppini
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

5.  Retroperitoneal fibrosis and scleroderma.

Authors:  M A Mansell; R W Watts
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

6.  Idiopathic retroperitoneal fibrosis presented as an abdominal mass and nephrotic syndrome.

Authors:  K H Oh; C Ahn; J H Park; J E Oh; H J Chin; J S Han; S Kim; J G Chi; M H Park; J S Lee
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.